I
Innoviva, Inc.
INVA · NASDAQ · Healthcare · 1.6B
Price · close
$21.07
+0.33% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
5.2×
Price / net assetsP/B
1.2×
Enterprise value / EBITDAEV/EBITDA
3.0×
Free cash flow yieldFCF yield
13.1%
Return on equityROE
23.1%
Operating margin
38.5%
Net debt / EBITDAbalance-sheet strength
-0.7×
Interest coverage
9.8×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.